China is confronting an outbreak of chikungunya fever, a mosquito-borne viral disease, primarily in the southern Guangdong province. Since early July, over 7,700 cases have been reported, with the city of Foshan being a core area of the outbreak. The surge has been exacerbated by heavy rainfall and thriving mosquito populations. In response, authorities have implemented a range of measures including real-name registration for fever and pain relief medication purchases, deployment of mosquito-eating fish, insecticide spraying, drone surveillance, installation of mosquito nets in drains, and fines for non-compliance. These efforts have led to a decline in new daily cases in Foshan since late July, with weekly new cases dropping from nearly 3,000 to 1,387 by early August. More than 90 percent of patients in Foshan have reportedly recovered. The outbreak has prompted the U.S. Centers for Disease Control and Prevention (CDC) to issue a Level 2 travel advisory for China, warning travelers of the mosquito-borne disease. Hong Kong has also reported imported cases, bringing its total to five. The World Health Organization has cautioned global attention to the spread of chikungunya. Despite the virus not being transmissible between humans, authorities in China have reinstated pandemic-style preventive measures reminiscent of COVID-19 responses to contain the virus. Meanwhile, other regions in Guangdong, including Zhongshan and Zhanjiang, have launched health campaigns to prevent further spread. The outbreak has drawn international attention amid concerns over mosquito-borne diseases in Asia.